SCHEMBL15537375

SCHEMBL15537375

CCOC(=O)c1nc(Cc2ccccc2)c(Br)s1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 4/20 0.49
DBF4 Q9UBU7 4/20 0.49
TRPM8 Q7Z2W7 1/20 0.49
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
RARA P10276 1/20 0.45
RARB P10826 1/20 0.45
RARG P13631 1/20 0.45
ALDH1A1 P00352 6/20 0.44
KDM4E B2RXH2 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
MAPT P10636 3/20 0.44
LMNA P02545 2/20 0.44
RAB9A P51151 2/20 0.44
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.42
NPC1 O15118 2/20 0.42
POLB P06746 1/20 0.41
PKM P14618 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1249830 0.83 CDC7 (0.54) CDC7DBF4TRPM8MEN1KMT2A
SCHEMBL1918920 0.80 CDC7 (0.56) CDC7DBF4TRPM8MEN1KMT2A
SCHEMBL693401 0.78 ALDH1A1 (0.57) CDC7DBF4TRPM8MEN1KMT2A
SCHEMBL15487393 0.78 PTGES (0.44) CDC7DBF4TRPM8MEN1KMT2A
SCHEMBL19207884 0.77 KMT2A (0.52) CDC7DBF4TRPM8MEN1KMT2A
SCHEMBL15537220 0.76 SMN1; SMN2 (0.45) CDC7DBF4TRPM8MEN1KMT2A
SCHEMBL19224496 0.74 LMNA (0.50) CDC7DBF4TRPM8MEN1KMT2A
SCHEMBL289991 0.74 ALDH1A1 (0.43) CDC7DBF4ALDH1A1KDM4ESMN1; SMN2
SCHEMBL19224653 0.73 ALDH1A1 (0.47) CDC7DBF4TRPM8MEN1KMT2A
SCHEMBL1919487 0.73 CDC7 (0.58) CDC7DBF4TRPM8MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10301272-B2 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] PHENEX PHARMACEUTICALS AG (DE) 2019-05-28 US disclosed
US-20150175562-A1 CARBOXAMIDE OR SULFONAMIDE SUBSTITUTED THIAZOLES AND RELATED DERIVATIVES AS MODULATORS FOR THE ORPHAN NUCLEAR RECEPTOR ROR[GAMMA] PHENEX PHARMACEUTICALS AG (DE) 2015-06-25 US disclosed
EP-2855440-A1 CARBOXAMIDE OR SULFONAMIDE SUBSTITUTED THIAZOLES AND RELATED DERIVATIVES AS MODULATORS FOR THE ORPHAN NUCLEAR RECEPTOR ROR[GAMMA] Phenex Pharmaceuticals AG (DE) 2015-04-08 EP disclosed
WO-2013178362-A1 CARBOXAMIDE OR SULFONAMIDE SUBSTITUTED THIAZOLES AND RELATED DERIVATIVES AS MODULATORS FOR THE ORPHAN NUCLEAR RECEPTOR ROR[GAMMA] PHENEX PHARMACEUTICALS AG (DE) 2013-12-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175562-A1 CARBOXAMIDE OR SULFONAMIDE SUBSTITUTED THIAZOLES AND RELATED DERIVATIVES AS MODULATORS FOR THE ORPHAN NUCLEAR RECEPTOR ROR[GAMMA] RORA, RORB, RORC CDC7 4386/4885DBF4 4465/4885TRPM8 477/4885
US-10301272-B2 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] RORA, RORB, RORC CDC7 4389/4885DBF4 4410/4885TRPM8 461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.